loading
Precedente Chiudi:
$8.57
Aprire:
$8.69
Volume 24 ore:
32,113
Relative Volume:
0.46
Capitalizzazione di mercato:
$237.24M
Reddito:
$21.25M
Utile/perdita netta:
$-16.05M
Rapporto P/E:
-13.89
EPS:
-0.61
Flusso di cassa netto:
$-17.14M
1 W Prestazione:
-12.99%
1M Prestazione:
-3.25%
6M Prestazione:
+69.16%
1 anno Prestazione:
+91.74%
Intervallo 1D:
Value
$8.357
$8.79
Intervallo di 1 settimana:
Value
$8.357
$9.81
Portata 52W:
Value
$3.96
$9.92

Fennec Pharmaceuticals Inc Stock (FENC) Company Profile

Name
Nome
Fennec Pharmaceuticals Inc
Name
Telefono
(919) 636-4530
Name
Indirizzo
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Name
Dipendente
32
Name
Cinguettio
@FennecPharma
Name
Prossima data di guadagno
2025-03-10
Name
Ultimi documenti SEC
Name
FENC's Discussions on Twitter

Confronta FENC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
FENC
Fennec Pharmaceuticals Inc
8.50 238.52M 21.25M -16.05M -17.14M -0.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.18 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
471.45 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
552.96 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
808.25 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
330.21 35.16B 4.56B -176.77M 225.30M -1.7177

Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-11-22 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2022-09-07 Iniziato CapitalOne Overweight
2022-08-08 Ripresa Craig Hallum Buy
2020-06-05 Iniziato Cantor Fitzgerald Overweight
2018-10-11 Iniziato Goldman Buy

Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie

pulisher
08:10 AM

Is Fennec Pharmaceuticals Inc. stock ready for breakoutWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com

08:10 AM
pulisher
08:08 AM

Why analysts raise outlook for Fennec Pharmaceuticals Inc. (RV41) stock2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com

08:08 AM
pulisher
01:12 AM

Can Fennec Pharmaceuticals Inc. stock withstand economic slowdown2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com

01:12 AM
pulisher
Oct 12, 2025

(FRX) Equity Market Report (FRX:CA) - news.stocktradersdaily.com

Oct 12, 2025
pulisher
Oct 12, 2025

Can Fennec Pharmaceuticals Inc. stock deliver consistent earnings growthMarket Movement Recap & Verified Technical Signals - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Rostislav Christov Raykov Buys 4,609 Shares of Fennec Pharmaceuticals (TSE:FRX) Stock - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Fennec Pharmaceuticals (TSE:FRX) Director Chris Anigeron Rallis Sells 1,775 Shares - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$256,237.35 in Stock - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Fennec Pharmaceuticals (TSE:FRX) Insider Southpoint Capital Advisors Lp Sells 26,900 Shares - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$265,650.01 in Stock - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Analysts Set Adherex Technologies Inc. (NASDAQ:FENC) Price Target at $13.33 - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

Long term hold vs stop loss in Fennec Pharmaceuticals Inc.Weekly Earnings Recap & Low Risk High Reward Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Fennec Pharmaceuticals (TSE:FRX) Shares Pass Above 50 Day Moving AverageHere's What Happened - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Southpoint sells Fennec Pharmaceuticals (FENC) shares worth $636k By Investing.com - Investing.com Canada

Oct 10, 2025
pulisher
Oct 10, 2025

(FRX) Trading Report (FRX:CA) - news.stocktradersdaily.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is now a turning point for Fennec Pharmaceuticals Inc.July 2025 Update & Real-Time Chart Pattern Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Southpoint sells Fennec Pharmaceuticals (FENC) shares worth $636k - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Fennec Pharmaceuticals Inc. stock trend forecast2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How Fennec Pharmaceuticals Inc. (RV41) stock benefits from digital adoptionJuly 2025 Opening Moves & Fast Gaining Stock Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Fennec Pharmaceuticals Inc. stock recover after recent dropJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Fennec Pharmaceuticals Inc. stock benefit from AI adoptionPortfolio Performance Summary & Smart Money Movement Tracker - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can Fennec Pharmaceuticals Inc. stock hit analyst price targetsRate Cut & High Conviction Buy Zone Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can Fennec Pharmaceuticals Inc. rally from current levelsJuly 2025 Movers & High Yield Equity Trading Tips - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Adherex Technologies (NASDAQ:FENC) Trading Down 1.4% After Insider Selling - Defense World

Oct 07, 2025
pulisher
Oct 07, 2025

Learn to Evaluate (FRX) using the Charts (FRX:CA) - news.stocktradersdaily.com

Oct 07, 2025
pulisher
Oct 07, 2025

What drives Fennec Pharmaceuticals Inc stock priceDividend Stability Analysis & Free Take Advantage Of Momentum - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

Fennec Pharmaceuticals (TSE:FRX) Reaches New 1-Year HighStill a Buy? - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $97,800 - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

What downside risks could hit Fennec Pharmaceuticals Inc. (RV41) stockPortfolio Performance Summary & Real-Time Sentiment Analysis - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using AI based signals to follow Fennec Pharmaceuticals Inc.July 2025 Summary & Safe Capital Preservation Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Fennec Pharmaceuticals Inc. stock positioned well for digital economy2025 Historical Comparison & Real-Time Stock Entry Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How buyback programs support Fennec Pharmaceuticals Inc. (RV41) stockWall Street Watch & Technical Entry and Exit Alerts - newser.com

Oct 06, 2025
pulisher
Oct 04, 2025

(FRX) Equity Trading Insights (FRX:CA) - news.stocktradersdaily.com

Oct 04, 2025
pulisher
Oct 03, 2025

Using Ichimoku Cloud for Fennec Pharmaceuticals Inc. technicalsOptions Play & High Accuracy Trade Signal Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Chart based analysis of Fennec Pharmaceuticals Inc. trendsQuarterly Portfolio Review & Risk Managed Investment Strategies - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can Fennec Pharmaceuticals Inc. (RV41) stock sustain double digit ROEJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

Fennec Pharmaceuticals Hits Day High with Strong 7.98% Intraday Surge - Markets Mojo

Oct 01, 2025
pulisher
Sep 30, 2025

Fennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month HighTime to Buy? - MarketBeat

Sep 30, 2025

Fennec Pharmaceuticals Inc Azioni (FENC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Fennec Pharmaceuticals Inc Azioni (FENC) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Southpoint Capital Advisors LP
10% Owner
Oct 07 '25
Sale
9.59
26,900
257,893
4,050,314
Southpoint Capital Advisors LP
10% Owner
Oct 09 '25
Sale
9.35
20,609
192,614
4,010,100
Southpoint Capital Advisors LP
10% Owner
Oct 08 '25
Sale
9.47
19,605
185,722
4,030,709
Raykov Rosty
Director
Oct 08 '25
Option Exercise
2.45
4,609
11,292
87,110
Raykov Rosty
Director
Oct 06 '25
Sale
9.78
10,000
97,800
82,501
$84.60
price up icon 0.96%
$22.93
price up icon 7.33%
$32.48
price up icon 2.06%
$102.75
price up icon 0.73%
$166.05
price up icon 2.27%
biotechnology ONC
$331.09
price up icon 3.38%
Capitalizzazione:     |  Volume (24 ore):